Maxor National Pharmacy Services, LLC

A rare disease is a disease that affects fewer than 200,000 Americans. More than 30 million people in the U.S. are living with a rare disease—that’s more than the population of Texas! At Maxor Specialty Pharmacy, we are dedicated to supporting patients with rare and complex conditions, ensuring they receive expert care and access to life-changing treatments. Providing specialized expertise and personalized care is essential, which is why Maxor is proud to be a URAC Rare Disease Center of Excellence. In our latest blog, we explore the more commonly diagnosed rare diseases and the impact they have on patients' lives. Read the full blog to learn more: https://lnkd.in/gNFiDQUM

Happy National Doctor’s Day! Today, we celebrate the dedication, compassion, and expertise of doctors who work tirelessly to keep our communities healthy. Your dedication not only saves lives but also inspires those around you. Thank you for your resilience, your empathy, and your relentless pursuit of better health outcomes. Join us in showing appreciation for the doctors in your life—drop a comment below to share a story or simply say thank you!

It’s time for our monthly spotlight of newly approved drugs, including a new copper-based IUD and an expanded indication of tenecteplase to treat acute ischemic stroke (AIS). Scroll through each image to learn more. Curious about recent and upcoming drug approvals? Check out our Q1 2025 Drug Pipeline Report for more insights: https://lnkd.in/geh8hNaC

Learn more about Maxor's Abel Haile in this 340B Report Industry Leader Spotlight! Find out a few of Abel’s favorite things as well as how his career has evolved in the 340B space.

The legal landscape surrounding the 340B program continues to evolve, but where is it headed? In our latest webinar, Emily Cook, Partner at McDermott, Will & Emery, breaks down the legal battles shaping the 340B program, key challenges driving ongoing legislation, and what to expect in the coming years. Check out a sneak peek of Emily’s answer below, and watch the full webinar to learn more: https://lnkd.in/gY2rS2td

A recent study by Jasninder S. Dhaliwal and?Ashujot Kaur Dang found that 27% of hospital readmissions during the first 30 days after discharge are potentially preventable. At Maxor, we’re helping hospitals reduce readmissions, boost patient satisfaction, and improve outcomes through coordinated pharmacy-led care. In one case, readmissions dropped 79% and pharmacy revenue increased 125%. Download our full report to see how Transition Care Management is improving patient outcomes and satisfaction: https://lnkd.in/gWyvXSUw

See you in Houston next week at #AMCP2025! Stop by Booth #804 and learn how we create value for your plan and better outcomes for your members.? Reach out to our team to connect at the show: Ian Parnigoni, Jolene Rode, Linda Maus, Danielle Boutte-Smothers, Dorothy Scarpignato, Lauren Love Compton, Derek Bergquist, Renée Baggett, Angie Oster, Michelle Brisco Fields, Paul Fischer

Today is National Native American HIV/AIDS Awareness Day, a time to raise awareness, encourage testing, and promote access to treatment for American Indian (AI) and Alaska Native (AN) communities. Key Facts AI/AN men are nearly twice as likely to be diagnosed with HIV compared to non-Hispanic white men. AI/AN women are more than 1.5 times as likely to be diagnosed and nearly 3 times as likely to die from HIV as non-Hispanic white women. An estimated 34% of AI/AN individuals living with HIV don’t know they have it. These disparities highlight the urgent need for awareness, testing, and access to care. Together, we can work toward health equity and support AI/AN communities in the fight against HIV/AIDS. Learn more: https://lnkd.in/gd7x8KFc

Critics argue that some covered entities profit from 340B without reinvesting in patient care—but is that the full story? In our latest webinar, Nicole Shoquist, Chief Pharmacy Officer at JPS Health Network, challenges skeptics to visit safety-net hospitals and see the impact firsthand. With programs like mobile clinics, safety-net hospitals meet patients where they are with critical services, making 340B savings the backbone of essential community care. Without 340B, what happens to these access points? Watch a sneak peek of Nicole’s answer below, and watch the full webinar to hear the reality from the front lines: https://lnkd.in/gY2rS2td

Looking for a PGY2 Match? Maxor is recruiting for our PGY2 Specialty Pharmacy Administration and Leadership (SPAL) Residency Program—one of the most unique and comprehensive programs in the nation! Who Should Apply? Current PGY1 residents or graduates of an ASHP-accredited PGY1 residency. Why Maxor? Enterprise-level experience with a focus on specialty pharmacy, administration, and leadership. Flexible, remote-friendly structure with on-site experiences in specialty pharmacies across the U.S. ASHP-accredited program offering hands-on training and leadership development. Join a program designed to shape the next generation of specialty pharmacy leaders! Learn more: https://lnkd.in/gnhCX9gW Contact Bonnie Dugie, Residency Program Director at [email protected]